We would like to extend a warm welcome to Dr. Roberto Vélez, Dr. Manolo Perez, Dr. Mario Aguirre, and Alba López at Hospital Vall d’Hebron, which is the latest site to attain enrolment-ready status and is the first European site to participate in the trial. There are currently 35 sites actively screening and enrolling patients into the PARITY trial across 7 countries (Canada, the United States, Australia, Argentina, South Africa, Brazil and Spain).
We would also like to thank Dr. Vélez for his dedication to the study and his oversight of the European start-up process! We will continue to update European sites that have expressed an interest in participating in PARITY as we continue to complete the necessary steps in order to initiate the trial throughout Europe.
Hospital Vall d’Hebron in Barcelona, Spain.